載入...

032. Moxifloxacin pharmacokinetics in patients with lung infection from 
non-tuberculous mycobacteria

BACKGROUND: Lung infection from non-tuberculous mycobacteria (NTM), represent a significant clinical problem due to its increased incidence and difficult management. Moxifloxacin (MXF) can play an important role in the treatment of these infections, especially when microbial resistance is an issue....

全面介紹

Na minha lista:
書目詳細資料
發表在:J Thorac Dis
Main Authors: Manika, Katerina, Chatzika, Kalliopi, Kipourou, Maria, Lada, Martha, Zarogoulidis, Konstantinos, Kioumis, Ioannis
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332104/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB032
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!